Group One Trading
HEPA

Group One Trading’s Hepion Pharmaceuticals HEPA Stock Holding History

Group One Trading’s Portfolio HEPA Stock Details HEPA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-86
Closed -$21.5K – 7699
2023
Q3 		$21.5K Sell
86
-2
-2% -$747 ﹤0.01% 5838
2023
Q2 		$46.2K Buy
88
+79
+878% +$48.5K ﹤0.01% 5341
2023
Q1 		$7.07K Buy
9
+5
+125% +$3.69K ﹤0.01% 6130
2022
Q4 		$1.26K Sell
4
-4
-50% -$1.69K ﹤0.01% 6777
2022
Q3 		$4K Sell
8
-3
-27% -$1.83K ﹤0.01% 6920
2022
Q2 		$7K Sell
11
-58
-84% -$48.3K ﹤0.01% 6936
2022
Q1 		$89K Sell
69
-81
-54% -$89.5K ﹤0.01% 5604
2021
Q4 		$171K Sell
150
-238
-61% -$326K ﹤0.01% 5237
2021
Q3 		$593K Buy
388
+172
+80% +$275K ﹤0.01% 3995
2021
Q2 		$427K Sell
216
-83
-28% -$152K ﹤0.01% 4389
2021
Q1 		$550K Buy
299
+262
+708% +$574K ﹤0.01% 3930
2020
Q4 		$82K Buy
+37
New +$95.9K ﹤0.01% 4698

Other funds holding HEPA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Group One Trading's HEPA Position: Q2 2025 in Review

Group One Trading sold out of Hepion Pharmaceuticals (HEPA) in Q2 2025, closing a stake of 4 shares — an estimated $2 sold.

Group One Trading first reported a position in HEPA in Q4 2020 and held it in 18 quarters. The position peaked at $195K in Q1 2021. 4 funds tracked by Wall St. Rank hold HEPA as of Q2 2025.

  • Group One Trading reported no remaining Hepion Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 4 Hepion Pharmaceuticals shares in Q2 2025, an estimated $2.
  • Group One Trading first reported a position in Hepion Pharmaceuticals in Q4 2020 and held it in 18 quarters.
  • Group One Trading's Hepion Pharmaceuticals position peaked at $195K in Q1 2021.
  • 4 funds tracked by Wall St. Rank held Hepion Pharmaceuticals as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.